Malignant tumor
Clinical trials for Malignant tumor explained in plain language.
Never miss a new study
Get alerted when new Malignant tumor trials appear
Sign up with your email to follow new studies for Malignant tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Sugar-Coated proteins on cancer cells
Disease control OngoingResearchers are testing an experimental oral drug called PhOx430 in people with advanced solid tumors, including glioblastoma and triple-negative breast cancer. The trial has two parts: first, they give increasing doses to small groups to find a safe dose and watch for side effec…
Matched conditions: MALIGNANT TUMOR
Phase 1 • Sponsor: Phost'In Therapeutics • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Experimental immune therapy targets EBV-Linked cancers in early trial
Disease control OngoingThis early-stage study tests a new immune-based treatment for people with advanced cancers linked to the Epstein-Barr virus (EBV) who have not responded to standard therapies. Only 6 participants are enrolled to check if the treatment is safe and to get a first look at whether it…
Matched conditions: MALIGNANT TUMOR
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a smaller dose of a white blood cell booster protect cancer patients just as well?
Prevention By invitation onlyResearchers are studying whether a lower 3mg dose of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) can prevent febrile neutropenia, a serious drop in infection-fighting white blood cells, in cancer patients after chemotherapy. The standard 6mg do…
Matched conditions: MALIGNANT TUMOR
Sponsor: Zhejiang Provincial People's Hospital • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC